Navigation Links
Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock ,,, Gel-Heavy

Phase Lock Gel may be used in conjunction with TRIzol Reagent for the isolation of total RNA from cell and tissue samples. Increased yields are observed using this method, because the entire aqueous phase can be recovered without interphase contamination. Below is a protocol outlining the steps involved in RNA isolation with TRIzol Reagent and Phase Lock Gel-Heavy. For further details about TRIzol Reagent, please refer to TRIzol Reagent protocol.

IMPORTANT: When working with TRIzol Reagent, use appropriate protective clothing and work under a chemical fume hood.

  1. Homogenization:
    1. Tissues: Add 1 ml TRIzol Reagent per 50100 mg tissue and homogenize with a POLYTRON homogenizer. For 110 mg quantities of tissue, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
    2. Cells grown in a Monolayer: Lyse cells by adding 1 ml TRIzol Reagent per 10 cm2 area of culture dish. Pipette suspension several times to disrupt cells. For 102104 cells, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
    3. Cells grown in Suspension: Pellet cells by centrifugation. Do not wash cell pellet. Add 1 ml TRIzol Reagent per 510 x 106 animal, plant, or yeast cells or 1 x 107 bacterial cells. Resuspend pellet by pipetting to lyse cells. For 102104 cells, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
  2. Pre-spin the appropriate sized Phase Lock Gel-Heavy tubes briefly to collect gel on tube bottoms (1500 x g for 30 seconds is sufficient to collect gel at tube bottoms).
  3. Add cell lysate to the tubes containing pre-spun Phase Lock Gel-Heavy and incubate 5 minutes at 1530C.
  4. Add 0.2 ml chloroform (or chloroform-isoamyl alcohol) per 1 ml TRIzol Reagent initially used. Cap tubes and shake vigorously for 15 seconds. DO NOT VORTEX!
  5. Centrifuge samples at no more than 12,000 x g for 10 minutes at 28C.
    NOTE: 15 ml and 50 ml PLG-H screw-cap tubes should be centrifuged at or below 2000 x g.
  6. Examine phasing. Clear, aqueous phase should be entirely atop Phase Lock Gel. The phenol-chloroform phase and cloudy interphase should be below Phase Lock Gel layer. If this is not the case, add another 0.2 ml chloroform (or chloroform-isoamyl alcohol) per 1 ml TRIzol Reagent used initally and shake vigorously. Repeat centrifugation and re-examine phasing.
  7. Transfer aqueous phase containing RNA to a fresh tube (aqueous phase may be decanted).
  8. Precipitate RNA by adding 0.5 ml Isopropyl alcohol per 1 ml TRIzol Reagent used initially. Mix samples by repeated inversion. Allow samples to incubate at 1530C for 10 minutes. Centrifuge samples for 10 minutes at no more than 12,000 x g, 28C. RNA pellet should be visible on side and bottom of tube.
  9. Decant supernatant. Add 1 ml 75% ethanol per 1 ml TRIzol Reagent used initially to wash the RNA pellet. Mix samples to dislodge pellet, using a vortex if necessary. Centrifuge samples at no more than 7,500 x g for 5 minutes at 28C.
  10. Carefully decant supernatant. Briefly air-dry or vacuum-dry the RNA pellet to remove residual ethanol (510 minutes). Do not overdry pellet by centrifugation under vacuum as this will make resuspension more difficult. Dissolve RNA pellet in Molecular Biology Grade water, incubating at 5560C for 10 minutes to facilitate dissolution.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. New Protocols for Isolating High- Molecular-Weight Genomic DNA
2. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
3. Lambda DNA Extraction Protocol
4. M13/Phagemid DNA Extraction Protocol
5. Mouse Tail Genomic DNA Isolation Protocol(1)
6. Genomic DNA Isolation Protocol(1,2,3)
7. Basic Plasmid DNA Isolation Protocol
8. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
9. RNA-free Plasmid DNA Isolation Protocol
10. Lambda DNA Extraction Protocol
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
Post Your Comments:
(Date:11/21/2008)...Call/ -- BioMarin Pharmaceutical,Inc. (Nasdaq: ...hief Medical,Officer will retire from the company... leave his position with the company to allow him ... endeavors related to rare diseases. Dr.,Kakkis ...or the foreseeable,future. , "I am extreme...
(Date:11/21/2008)...Call/ -- CorVel Corporation,(Nasdaq: CRVL ) ann...er the new,Medicare legislation requiring expande...ors and employers. The Company currently provides...ompensation and general liability,customers throu...ffering to,include communications soon to be mand...
(Date:11/21/2008)...e Center is First Integrated Knowledge Center Outs...Hyderabad, India (Vocus) November 21, 2008 -&ndash...today, 17 months after breaking ground last summer... in the city’s Genome Valley, the center wil... region in the areas of agricultural and industria...
(Date:11/21/2008)...UCTURING ALTERNATIVES ONGOING , , VANCOUVER...aceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a gl...ompany, today announced that the Company had been ...nture Partners (New Leaf) that they had elected to...7, 2008. Angiotech had announced on September 22, ...
Breaking Biology Technology:BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4CorVel Announces MSA Agent Services 2CorVel Announces MSA Agent Services 3DuPont Opens Research & Development Center in India 2DuPont Opens Research & Development Center in India 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4
... Stratagenes custom molecular beacon synthesis a... , Fei Bao , University of Colorad... We used Stratagenes custom molecular beacons ff,...NP) in a region of chromosome,10q25.1 and showed...s carried in,family members. This molecular beac...
...,,,, Culture 192 clones simul...ff Braman ,Stratagene , , , F... , The tempest thermoshaker and a 96-deep-w...ate bacterial clones in a, high-throughput ...l growth, were equivalent in aerated and no...
...,, Many different tissue types on a con...as ,Stratagene , Stratagenes Complete View t...issue array technology through optimized,tissue ...issue morphology,antigenicity of proteins, and ...,line consists of murine (male and female) survey ...
... Produce large quantities of difficult-to-express...rd Becker ,Biochemical & Molecular Allergology, ...tagenes BL21-CodonPlus(DE3)-RIL cells * with,ext...nes,it is possible to attain high-level express... usage: IPTG-induced expression of several recombi...
Other Biology Technology:Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 2Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 3Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 4Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 5Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 6High-Throughput Cultivation of Bacterial Clones 2High-Throughput Cultivation of Bacterial Clones 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 2Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 4Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 5High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4
(Date:11/20/2008)...the ocean floor made by giant deep-sea single-cell...volutionary origin of animals, says biologist Mikh...ustin. , Matz and his colleagues recently disco...racks on the ocean floor near the Bahamas. This is...shown to make such animal-like traces. , The fin...
(Date:11/20/2008)...gical Institute at St. Joseph,s Hospital and Medic...e motions and the perception of illusory motion th...knik, PhD, director of the Laboratory of Behaviora...ector of the Laboratory of Visual Neuroscience; Xo...ucted a study based on the Enigma painting, a visu...
(Date:11/20/2008)...A team led by Thomas Schulthess of the U.S. Depart...eived the prestigious 2008 Association for Computi...r attaining the fastest performance ever in a scie...is group leader of ORNL,s Computational Materials ...director of the Swiss National Supercomputing Cent...
(Date:11/20/2008)... hates strangers. When its security patrol spots a...problem when people with type 1 diabetes undergo h...rom a donor pancreas produce robust amounts of ins...dence from insulin therapy. However, the immune sy... A person who has the transplant procedure must t...
Breaking Biology News(10 mins):Discovery of giant roaming deep sea protist provides new perspective on animal evolution 2Discovery of giant roaming deep sea protist provides new perspective on animal evolution 3ORNL supercomputer simulation wins prize for fastest-running science application 2ORNL supercomputer simulation wins prize for fastest-running science application 3Researcher tricks immune system in diabetic mice 2Video 3A Never Feel Bad About Your Neck Again 3A 27880 1Video 3A Never Feel Bad About Your Neck Again 3A 27880 2Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals 27876 1Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals 27876 2Catalyst Biosciences Appoints Dr Todd Lorenz Chief Medical Officer 27872 1Catalyst Biosciences Appoints Dr Todd Lorenz Chief Medical Officer 27872 2Catalyst Biosciences Appoints Dr Todd Lorenz Chief Medical Officer 27872 3PEAK Surgical Introduces PlasmaBlade 28TM 29 Product Line Extensions for Use in General Surgery 8655 1PEAK Surgical Introduces PlasmaBlade 28TM 29 Product Line Extensions for Use in General Surgery 8655 2PEAK Surgical Introduces PlasmaBlade 28TM 29 Product Line Extensions for Use in General Surgery 8655 3
...f Medicine researchers have discovered how new neu...nt to regions of the brain where they can replace ...tem cell therapies can be specifically targeted to...ses or by stroke. , Associate Professor Qun-Yong Z...artment of Pharmacology have identified a protein ...
... the world are breathing a sigh of relief, as they...ir natural disease-fighting substances. Scientists... didemnii, which lives symbiotically inside the se...es, compounds that may one day be used in cancer t...s could not successfully cultivate Prochloron in t...
...sma protein found in blood, can be fused with larg...stimulating factor (G-CSF) to create a new oral co...rough the gastrointestinal (GI) tract and then abl... the body, according to research from the Universi...is technology may allow for oral administration of...
...factors prove that BioMed Central,s Open Access jo... Journals published by BioMed Central have again r...valent subscription titles, it was announced today...lty. The high impact factors for these journals af...re fast becoming the place for authors to submit i...
Other Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3'Bionic' arm gives amputee sense of touch 2
Protein Marker Detection Pack contains biotinylate
JMJD2B Antibody
Agarose, Biotechnology grade, 500g
...to-oncogene was first identified as the cellular h...Jun B and Jun D have been shown to be almost ident...re involved in dimerization and DNA binding, where... transcriptional activation, diverge. Antigen: ...
Biology Products: